搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Haemophilus influenzae Adenylosuccinate synthetase (purA) CSB-YP403771HSD
CSB-EP403771HSD
CSB-BP403771HSD
CSB-MP403771HSD
CSB-EP403771HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Arginine repressor (argR) CSB-YP403772HSD
CSB-EP403772HSD
CSB-BP403772HSD
CSB-MP403772HSD
CSB-EP403772HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae S-adenosylmethionine synthase (metK) CSB-YP403773HSD
CSB-EP403773HSD
CSB-BP403773HSD
CSB-MP403773HSD
CSB-EP403773HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase CSB-YP403774HSD
CSB-EP403774HSD
CSB-BP403774HSD
CSB-MP403774HSD
CSB-EP403774HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Probable GTP-binding protein EngB (engB) CSB-YP403775HSD
CSB-EP403775HSD
CSB-BP403775HSD
CSB-MP403775HSD
CSB-EP403775HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae UPF0756 membrane protein CGSHiEE_06715 (CGSHiEE_06715), partial CSB-YP403776HSD1
CSB-EP403776HSD1
CSB-BP403776HSD1
CSB-MP403776HSD1
CSB-EP403776HSD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (ispH) CSB-YP403777HSD
CSB-EP403777HSD
CSB-BP403777HSD
CSB-MP403777HSD
CSB-EP403777HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae DNA-binding protein fis (fis) CSB-YP403778HSD
CSB-EP403778HSD
CSB-BP403778HSD
CSB-MP403778HSD
CSB-EP403778HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae UPF0758 protein CGSHiEE_07200 (CGSHiEE_07200) CSB-YP403779HSD
CSB-EP403779HSD
CSB-BP403779HSD
CSB-MP403779HSD
CSB-EP403779HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Glycine--tRNA ligase alpha subunit (glyQ) CSB-YP403780HSD
CSB-EP403780HSD
CSB-BP403780HSD
CSB-MP403780HSD
CSB-EP403780HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae RNA pyrophosphohydrolase (rppH) CSB-YP403781HSD
CSB-EP403781HSD
CSB-BP403781HSD
CSB-MP403781HSD
CSB-EP403781HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae GTPase obg (obg) CSB-YP403782HSD
CSB-EP403782HSD
CSB-BP403782HSD
CSB-MP403782HSD
CSB-EP403782HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein YjeA (yjeA) CSB-YP403783HSD
CSB-EP403783HSD
CSB-BP403783HSD
CSB-MP403783HSD
CSB-EP403783HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae 30S ribosomal protein S4 (rpsD) CSB-YP403784HSD
CSB-EP403784HSD
CSB-BP403784HSD
CSB-MP403784HSD
CSB-EP403784HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae 50S ribosomal protein L18 (rplR) CSB-YP403785HSD
CSB-EP403785HSD
CSB-BP403785HSD
CSB-MP403785HSD
CSB-EP403785HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae 50S ribosomal protein L29 (rpmC) CSB-YP403786HSD
CSB-EP403786HSD
CSB-BP403786HSD
CSB-MP403786HSD
CSB-EP403786HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Diaminopimelate epimerase (dapF) CSB-YP403787HSD
CSB-EP403787HSD
CSB-BP403787HSD
CSB-MP403787HSD
CSB-EP403787HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Proline--tRNA ligase (proS), partial CSB-YP403788HSD
CSB-EP403788HSD
CSB-BP403788HSD
CSB-MP403788HSD
CSB-EP403788HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae L-seryl-tRNA (Sec) selenium transferase CSB-YP403789HSD
CSB-EP403789HSD
CSB-BP403789HSD
CSB-MP403789HSD
CSB-EP403789HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae D-tyrosyl-tRNA (Tyr) deacylase CSB-YP403790HSD
CSB-EP403790HSD
CSB-BP403790HSD
CSB-MP403790HSD
CSB-EP403790HSD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>